KLOW Blend 80mg
Co-lyophilised research peptide blend: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg (80mg total net peptide content). Supplied as lyophilised powder for laboratory in-vitro research use only.
Investigated in pre-clinical models for matrix remodelling and collagen synthesis (Pickart & Margolina, Int. J. Mol. Sci., 2018), cytoprotective and angiogenic activity (Sikiric et al., Curr. Pharm. Des., 2010), cell-migration pathways (Goldstein et al., FASEB J., 2012) and NF-κB-mediated inflammatory signalling (Brzoska et al., Endocr. Rev., 2008).
Citations provided for pre-clinical reference only. Supplied strictly for in-vitro research — not a claim of clinical efficacy.
Items are held in your Zenitide basket. Review and proceed to secure checkout when ready.
- Dispatched in 24–48hOnce payment has cleared
- Insulated packagingProtects lyophilised compounds in transit
- Tracked UK deliveryTracking reference emailed on dispatch